|
Market Closed -
London S.E.
11:35:01 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 77.50 GBX | 0.00% |
|
-6.06% | -3.73% |
| 10-15 | Arecor Therapeutics Obtains Patents in Europe, US, India, for Rapid-acting Insulin | MT |
| 10-15 | Arecor Therapeutics Plc Strengthens Patent Protection For Its Proprietary AT278 Product | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | -6.06% | +6.90% | +29.17% | -3.73% | +6.90% | -59.21% | -81.10% | - | 47.3M | |
| -4.83% | +3.51% | -12.15% | +3.01% | +62.18% | +53.62% | +61.75% | +16.30% | - | 69.4B | |
| +0.02% | +1.42% | +0.42% | +8.98% | +13.81% | +12.77% | +75.21% | +195.69% | +6,359.22% | 57.24B | |
| -1.34% | +3.53% | +15.41% | +18.17% | +23.35% | +23.22% | +101.58% | -6.90% | +273.12% | 57.62B | |
| +2.62% | +1.68% | +4.56% | +16.95% | +20.59% | +28.91% | +37.01% | +9.97% | +274.47% | 43.65B | |
| +5.09% | +9.89% | +12.18% | +23.40% | +33.95% | +22.45% | +107.48% | +11.50% | +1,187.85% | 44.03B | |
| +8.24% | +0.51% | -3.80% | -2.80% | +141.41% | +213.26% | +792.66% | +470.56% | - | 38.08B | |
| -1.86% | +11.46% | +15.55% | +10.88% | +22.40% | +26.67% | +61.40% | +22.80% | +180.36% | 36.31B | |
| -2.97% | -6.89% | +48.38% | +86.42% | +74.00% | +91.79% | +74.60% | +17.33% | +204.58% | 32.61B | |
| -2.18% | +5.68% | -14.04% | +17.23% | +51.46% | +36.21% | -0.69% | -53.27% | - | 25.47B | |
| +5.19% | +1.62% | +8.72% | -13.69% | -34.27% | -38.39% | +379.89% | +242.22% | +920.56% | 23.86B | |
| +1.92% | -0.75% | -8.59% | -4.04% | -8.08% | -15.33% | -12.24% | -59.61% | - | 21.29B | |
| +2.86% | +0.17% | +8.33% | +11.64% | +16.28% | +10.29% | +142.46% | +189.19% | +2,008.85% | 17.76B | |
| +1.25% | +0.26% | +19.27% | +33.28% | +58.73% | +70.51% | +233.83% | +259.35% | +484.13% | 16.77B | |
| -0.45% | +1.79% | +17.34% | +27.21% | +42.05% | +50.08% | +72.12% | -11.24% | +122.16% | 17.35B | |
| +1.33% | +2.21% | +13.61% | +2.79% | - | - | - | - | - | 16.64B | |
| +7.17% | +6.72% | +8.09% | -1.55% | +199.74% | +176.23% | +331.87% | +1,547.39% | +865.04% | 14.86B | |
| +7.83% | -6.09% | +10.68% | +27.12% | +69.20% | +97.52% | +86.09% | -10.05% | +394.97% | 15B | |
| +1.53% | -3.13% | +26.63% | +27.03% | +12.36% | +27.96% | -20.60% | -23.02% | +167.81% | 15.11B | |
| +7.98% | +5.30% | +5.65% | +64.90% | +28.79% | +5.49% | - | - | - | 12.85B | |
| Average | +1.97% | +1.96% | +9.16% | +19.30% | +43.38% | +47.38% | +136.96% | +152.06% | +1,034.09% | 28.8B | |
| Weighted average by Cap. | +1.08% | +3.19% | +7.33% | +16.64% | +43.53% | +47.58% | +142.80% | +119.58% | +1,393.38% |
- Stock Market
- Stocks
- AREC Stock
- Sector Arecor Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
